<bill session="115" type="s" number="1348" updated="2017-09-22T12:43:17Z">
  <state datetime="2017-06-13">REFERRED</state>
  <status>
    <introduced datetime="2017-06-13"/>
  </status>
  <introduced datetime="2017-06-13"/>
  <titles>
    <title type="short" as="introduced">Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017</title>
    <title type="short" as="introduced">Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017</title>
    <title type="official" as="introduced">A bill to amend title XI of the Social Security Act to require drug manufacturers to publicly justify unnecessary price increases.</title>
    <title type="display">Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017</title>
  </titles>
  <sponsor bioguide_id="W000779"/>
  <cosponsors>
    <cosponsor bioguide_id="C000141" joined="2017-06-13"/>
    <cosponsor bioguide_id="C000174" joined="2017-06-13"/>
    <cosponsor bioguide_id="C001088" joined="2017-06-13"/>
    <cosponsor bioguide_id="D000622" joined="2017-08-02"/>
    <cosponsor bioguide_id="G000555" joined="2017-06-13"/>
    <cosponsor bioguide_id="S000770" joined="2017-06-13"/>
    <cosponsor bioguide_id="T000464" joined="2017-07-11"/>
  </cosponsors>
  <actions>
    <action datetime="2017-06-13">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-06-13" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Social Welfare"/>
  </subjects>
  <amendments/>
  <summary date="2017-06-13T04:00:00Z" status="Introduced in Senate">Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017

This bill amends title XI (General Provisions) of the Social Security Act to require manufacturers of&#160; drugs with specified percentage increases in their wholesale costs to submit to the Centers for Medicare &amp; Medicaid Services (CMS) written justification&#160;for&#160;certain increases in drug prices. The CMS shall&#160;publish each&#160;submission, together with an&#160;easily understandable summary, on its website. Certain proprietary information may be excluded from publication, as specified by the bill.

A manufacturer that does not comply with the bill's requirements&#160;shall be&#160;subject to civil monetary penalties.</summary>
  <committee-reports/>
</bill>
